IMO, the risk factors are fully built into the 3 to 4 cent share price. Elite can either build from scratch the Adderall distribution or make a deal with a new partner or even merge with a company that has existing distribution capability. I think the chance of success makes ELTP a very reasonable bet. BTW, I agree that no one will buy elite for 4 to 5 times the existing market cap at this time. ELTP has a real chance of getting to 15 cents a share, but not overnight.
News 
Market Data 
Discover 
